Home / Stocks / Procter & Gamble Health L
PGHL

Procter & Gamble Health L Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹5,536.5

Change

+31.5 (0.57%)

Open

₹5,505.0

Prev. Close

₹5,505.0

Day High

₹5,659.5

Day Low

₹5,461.5

Volume Analysis

Traded

7,906

Delivered

2,942

Delivery %

37.21%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (33.0%)

Weaknesses (0)

No signal for this stock

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹5,841.5 ₹5,750.5 ₹5,643.5 ₹5,552.5 ₹5,445.5 ₹5,354.5 ₹5,247.5
Fibonacci ₹5,750.5 ₹5,674.86 ₹5,628.14 ₹5,552.5 ₹5,476.86 ₹5,430.14 ₹5,354.5
Camarilla ₹5,590.95 ₹5,572.8 ₹5,554.65 ₹5,552.5 ₹5,518.35 ₹5,500.2 ₹5,482.05

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-3.25%

1 Week

-4.69%

1 Month

+9.68%

3 Months

-5.01%

6 Months

-0.3%

1 Year

-6.26%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

47.92%

Net margin 23.22% × asset turnover 1.34x × equity multiplier 1.54x

Company Overview

Sector

Healthcare

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Procter & Gamble Health L holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 73/100. The strongest factor is Financial Strength (100/100), while Institutional Ownership (34/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (33.0%). FII holding has been falling.

TopFund Score — Fundamentals Quality

73/100 — Good

Data confidence: 74/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

46

Cash Flow

95

Corporate Governance

56

Institutional Ownership

34

Business Quality

100

Risk & Volatility

62

Liquidity

50

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

SEBI special window for physical share transfer relodgement extended to February 4, 2027; RTA office moves December 1, 2026.

KFin Technologies shifts corporate office from 1 December 2026; company's registered office unchanged.

Press Release 02 Nov

Q2 FY26 sales rose 18% to ₹376 crore; PAT increased 26% to ₹112 crore.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 (S) Dec 2023 (S) Mar 2024 (S) Jun 2024 (S) Sep 2024 (S) Dec 2024 (S) Mar 2025 (S) Jun 2025 (S) Sep 2025 (S) Dec 2025 (S) Mar 2026 (S) Jun 2026 (S) Sep 2026 (S)
Sales + 305 310 252 284 313 310 311 339 325 374 370 364 382
Expenses + 216 208 185 236 199 186 230 248 205 263 235 264 230
Operating Profit 89 102 67 48 114 123 81 90 120 110 136 100 152
OPM % 29.0% 33.0% 27.0% 17.0% 36.0% 40.0% 26.0% 27.0% 37.0% 30.0% 37.0% 27.0% 40.0%
Other Income + 6 5 2 -18 3 4 3 4 5 4 4 36 4
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 6 7 7 7 6 6 5 5 6 6 6 6 6
Profit before tax 88 100 63 23 111 122 79 89 119 109 133 129 150
Tax % 26.0% 28.0% 26.0% 26.0% 26.0% 25.0% 22.0% 25.0% 26.0% 29.0% 29.0% 26.0% 26.0%
Net Profit + 66 72 47 17 82 91 61 66 89 78 95 96 112
EPS in Rs 40 43 28 10 50 55 37 40 53 47 57 58 67
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 2 0 -21 -6 3 0 23 19 4 21 19 7 18

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Dec 2015 (S) Dec 2016 (S) Dec 2017 (S) Dec 2018 (S) Dec 2019 (S) Jun 2020 (S) 18m Jun 2021 (S) Jun 2022 (S) Jun 2023 (S) Jun 2024 (S) Mar 2025 (S) 9m Mar 2026 (S)
Sales + 940 993 698 849 927 1,356 1,009 1,114 1,230 1,151 934 1,408
Expenses + 855 877 621 701 723 1,037 762 846 905 845 616 949
Operating Profit 85 116 77 148 204 319 246 268 325 307 319 459
OPM % 9.0% 12.0% 11.0% 17.0% 22.0% 24.0% 24.0% 24.0% 26.0% 27.0% 34.0% 33.0%
Other Income + 22 24 74 768 48 66 18 13 18 -5 10 15
Interest 0 0 0 0 0 0 1 0 1 1 0 1
Depreciation 23 25 19 21 17 29 30 27 28 27 17 24
Profit before tax 83 115 132 895 234 355 233 253 314 273 312 450
Tax % 36.0% 31.0% 29.0% 6.0% 32.0% 28.0% 24.0% 24.0% 27.0% 26.0% 25.0% 27.0%
Net Profit + 54 79 94 839 159 254 177 193 229 201 234 327
EPS in Rs 32 48 57 505 96 153 107 116 138 121 141 197
Dividend Payout % 23.0% 23.0% 27.0% 87.0% 0.0% 150.0% 122.0% 45.0% 69.0% 215.0% 89.0% 104.0%
Sales growth 8 6 -30 22 9 60 -26 10 10 -6 -24 51

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Dec 2015 (S) Dec 2016 (S) Dec 2017 (S) Dec 2018 (S) Dec 2019 (S) Jun 2020 (S) Jun 2021 (S) Jun 2022 (S) Jun 2023 (S) Jun 2024 (S) Mar 2025 (S) Mar 2026 (S) Sep 2026 (S)
Reserves 575 647 717 1,524 800 890 687 600 734 522 520 508 641
Borrowings + 0 0 0 0 0 0 8 3 12 10 8 9 7
Other Liabilities + 192 215 258 219 250 269 275 269 338 247 250 308 349
Total Liabilities 784 879 991 1,759 1,067 1,176 986 888 1,101 794 794 841 1,015
Fixed Assets + 132 111 115 104 101 101 104 112 144 128 116 102 102
CWIP 7 30 9 17 11 21 39 41 32 6 11 14 10
Investments 42 28 70 0 0 0 0 0 0 0 0 0 0
Other Assets + 603 711 797 1,639 954 1,053 843 736 925 660 667 726 902
Total Assets 784 879 991 1,759 1,067 1,176 986 888 1,101 794 794 841 1,015
Equity Capital 17 17 17 17 17 17 17 17 17 17 17 17 17

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Dec 2015 (S) Dec 2016 (S) Dec 2017 (S) Dec 2018 (S) Dec 2019 (S) Jun 2020 (S) Jun 2021 (S) Jun 2022 (S) Jun 2023 (S) Jun 2024 (S) Mar 2025 (S) Mar 2026 (S)
Cash from Operating Activity + 83 107 54 -130 — 235 247 170 236 228 169 338
Cash from Investing Activity + -68 -75 -48 1,270 — 165 -32 -26 -22 -7 10 1
Cash from Financing Activity + -12 -15 -22 -30 — -883 -387 -289 -98 -418 -235 -344
Net Cash Flow 4 17 -16 1,109 — -483 -172 -145 116 -197 -56 -5
Free Cash Flow 38 75 24 -157 — 212 196 132 198 207 168 323
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 136 138 147 117 — 106 128 87 100 102 78 96

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 51.82% → 51.82%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 27.92% 28.22% 27.24% 26.74% 26.47% 27.11% 27.03% 27.05% 27.37% 28.3% 29.41% 29.13%
Promoters 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82%
FII 7.6% 6.24% 6.39% 6.61% 7.01% 6.86% 6.99% 7.24% 6.97% 6.2% 6.33% 6.43%
DII 12.66% 13.72% 14.56% 14.84% 14.71% 14.21% 14.15% 13.9% 13.84% 13.67% 12.44% 12.63%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Procter & Gamble Health L (this stock) — — — —
Sun Pharmaceutical Ind L 451,075 36.7 5.05 16.0%
Divi S Laboratories Ltd 294,139 86.1 16.34 16.5%
Torrent Pharmaceuticals L 177,632 81.8 9.67 27.4%
Apollo Hospitals Enter. L 125,893 55.6 11.86 21.5%
Laurus Labs Limited 125,380 93.6 20.73 18.3%
Zydus Lifesciences Ltd 118,693 26.2 4.27 21.2%

Which Mutual Funds Hold Procter & Gamble Health L?

Frequently Asked Questions about Procter & Gamble Health L

Community Sentiment

What are other investors saying about Procter & Gamble Health L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.